Market Place
Sourcing Support
Senators want to know more on why Novo is discontinuing its insulin Levemir
20 Apr 2024 //
ENDPTS
Novo Nordisk to slash US insulin prices, following move by Eli Lilly
15 Mar 2023 //
REUTERS
Novo Nordisk Issues Voluntary Nationwide Recall of Levemir®
11 May 2021 //
FDA
Novo faces shareholder suit over insulin sales disclosures
16 Aug 2019 //
BIOPHARMADIVE
Novo Nordisk preps for speedy oral GLP-1 drug filing
01 Feb 2019 //
PM LIVE
Novo Nordisk sees revenues drop in Q2
09 Aug 2018 //
PHARMA TIMES
Celgene, Roche and Novo increased prices on some top sellers
13 Jul 2018 //
FIERCE PHARMA
Drugmakers Cancel Price Hikes After California Law Takes Effect
12 Jul 2018 //
BLOOMBERG
Novo`s Tresiba snags FDA nod highlighting hypo safety
26 Mar 2018 //
FIERCE PHARMA
Tracking a successful DLBCL assault in PhII, MorphoSys out to OK for MOR208
14 Mar 2018 //
PLATFORM
Toujeo® reduced risk of severe low blood sugar compared to insulin glargine
14 Feb 2018 //
PRESS RELEASE
Novo says real-world data backs its insulin switching
13 Jun 2017 //
PMLIVE
Top 10 diabetes drugs by 2016 sales
08 Jun 2017 //
FIERCE PHARMA
Novo Receives FDA Approval of Tresiba with Diabetes
20 Dec 2016 //
PR NEWSWIRE
Voluntis scores U.S., EU nods for Type 2 diabetes management software
06 Dec 2016 //
FIERCE BIOTECH
Drugmakers Find Competition Doesn’t Keep a Lid on Prices
28 Nov 2016 //
WALL STREET JOURNAL
Sanders calls for federal investigation of insulin makers for price collusion
03 Nov 2016 //
STAT
Sanofi patent deal lets Lilly roll out a Lantus biosim in U.S. next December
29 Sep 2015 //
FIERCE PHARMA
Restricted Access Essentials for Pharma
14 Sep 2015 //
PHARMA EXEC
Will pricey new drug classes take the wind out of diabetes launches?
20 Aug 2015 //
FIERCE PHARMA MARKETING
Pharma hikes prices on all sorts of meds, but hit diabetes hardest: Bloomberg
07 May 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.